Le Lézard
Classified in: Health
Subjects: MAV, NPT, CHI, FVT

Press Invitation - The Leucan Christmas Party: A Long-Awaited Event for Families


MONTREAL, Dec. 8, 2017 /CNW Telbec/ - Leucan, the Association for children with cancer and their families, invites you to its Christmas Party to be held this Sunday, December 10, 2017, from 1 p.m. to 4 p.m., at Amiens Reception Halls in Saint-Léonard.

More than 75 families from the Montreal area will gather this Sunday to celebrate Christmas and forget their difficult circumstances for a short while. Les Grands Ballets Canadiens de Montréal, Végane and Pixelle from the television youth program Les Salmigondis, and Santa Claus will also be in attendance to entertain the young and the young at heart. This Sunday, please join us and see the holiday magic shine bright in the eyes of the families of Leucan.

 

Event

Leucan Montréal-Laval's Christmas Party

Time

Sunday, December 10, 1 p.m.- 4 p.m.

Location

Amiens Reception Halls

8700 Langelier Blvd., Saint-Léonard, QC H1P 3C6

In attendance

  • Member families of Leucan
  • Carol Beaudry, Director, Family Services, Research and Partnership

 

SOURCE Leucan


These press releases may also interest you

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...



News published on and distributed by: